Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

J. Cell Biol. 177 (6): 1119-1132

Copyright © 2007 by the Rockefeller University Press.


Article

p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway

Benjamin D. Sachs1, George S. Baillie2, Julianne R. McCall1, Melissa A. Passino1, Christian Schachtrup1, Derek A. Wallace2, Allan J. Dunlop2, Kirsty F. MacKenzie2, Enno Klussmann3, Martin J. Lynch2, Shoana L. Sikorski1, Tal Nuriel1,4, Igor Tsigelny1, Jin Zhang1, Miles D. Houslay2, Moses V. Chao4, , and Katerina Akassoglou1

1 Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093
2 Molecular Pharmacology Group, Biochemistry & Molecular Biology, University of Glasgow, Glasgow G12 8QQ, Scotland, UK
3 Leibniz-Institut für Molekulare Pharmakologie (FMP), Campus Berlin-Buch,13125 Berlin, Germany
4 Molecular Neurobiology Program, Skirball Institute of Biomolecular Medicine, Departments of Cell Biology, Physiology, and Neuroscience, New York University School of Medicine, New York, NY 10016

Correspondence to Katerina Akassoglou: akass{at}ucsd.edu

Abstract: Clearance of fibrin through proteolytic degradation is a critical step of matrix remodeling that contributes to tissue repair in a variety of pathological conditions, such as stroke, atherosclerosis, and pulmonary disease. However, the molecular mechanisms that regulate fibrin deposition are not known. Here, we report that the p75 neurotrophin receptor (p75NTR), a TNF receptor superfamily member up-regulated after tissue injury, blocks fibrinolysis by down-regulating the serine protease, tissue plasminogen activator (tPA), and up-regulating plasminogen activator inhibitor-1 (PAI-1). We have discovered a new mechanism in which phosphodiesterase PDE4A4/5 interacts with p75NTR to enhance cAMP degradation. The p75NTR-dependent down-regulation of cAMP results in a decrease in extracellular proteolytic activity. This mechanism is supported in vivo in p75NTR-deficient mice, which show increased proteolysis after sciatic nerve injury and lung fibrosis. Our results reveal a novel pathogenic mechanism by which p75NTR regulates degradation of cAMP and perpetuates scar formation after injury.

T. Nuriel's present address is Weill Medical School of Cornell University, 1300 York Avenue, New York, NY 10021.

J. Zhang's present address is Department of Pharmacology and Molecular Sciences and Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.

Abbreviations used in this paper: 3D, three-dimensional; BDNF, brain-derived neurotrophic factor; CGN, cerebellar granule neuron; FL, full length; FRET, fluorescence resonance energy transfer; ICD, intracellular domain; IP, immunoprecipitation; LPS, lipopolysaccharide; MS, multiple sclerosis; NGF, nerve growth factor, p75NTR, p75 neurotrophin receptor; PA, plasminogen activator; PAI-1, plasminogen activator inhibitor-1; PDE, phosphodiesterase; PTX, pertussis toxin; SC, Schwann cell; tPA, tissue plasminogen activator; uPA, urokinase plasminogen activator; wt, wild-type.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
p75 Neurotrophin Receptor Is a Clock Gene That Regulates Oscillatory Components of Circadian and Metabolic Networks.
B. Baeza-Raja, K. Eckel-Mahan, L. Zhang, E. Vagena, I. F. Tsigelny, P. Sassone-Corsi, L. J. Ptacek, and K. Akassoglou (2013)
J. Neurosci. 33, 10221-10234
   Abstract »    Full Text »    PDF »
ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation.
C.-J. Siao, C. U. Lorentz, P. Kermani, T. Marinic, J. Carter, K. McGrath, V. A. Padow, W. Mark, D. J. Falcone, L. Cohen-Gould, et al. (2012)
J. Exp. Med. 209, 2291-2305
   Abstract »    Full Text »    PDF »
p75 neurotrophin receptor regulates glucose homeostasis and insulin sensitivity.
B. Baeza-Raja, P. Li, N. Le Moan, B. D. Sachs, C. Schachtrup, D. Davalos, E. Vagena, D. Bridges, C. Kim, A. R. Saltiel, et al. (2012)
PNAS 109, 5838-5843
   Abstract »    Full Text »    PDF »
Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation.
B. M. Connolly, E. Y. Choi, H. Gardsvoll, A. L. Bey, B. M. Currie, T. Chavakis, S. Liu, A. Molinolo, M. Ploug, S. H. Leppla, et al. (2010)
Blood 116, 1593-1603
   Abstract »    Full Text »    PDF »
Mdm2 Directs the Ubiquitination of {beta}-Arrestin-sequestered cAMP Phosphodiesterase-4D5.
X. Li, G. S. Baillie, and M. D. Houslay (2009)
J. Biol. Chem. 284, 16170-16182
   Abstract »    Full Text »    PDF »
Multiple Roles of the p75 Neurotrophin Receptor in the Nervous System.
Y. Chen, J. Zeng, Y. Chen, X. Wang, G. Yao, W. Wang, W. Qi, and K. Kong (2009)
Journal of International Medical Research 37, 281-288
   Abstract »    PDF »
The Hemopexin Domain of Matrix Metalloproteinase-9 Activates Cell Signaling and Promotes Migration of Schwann Cells by Binding to Low-Density Lipoprotein Receptor-Related Protein.
E. Mantuano, G. Inoue, X. Li, K. Takahashi, A. Gaultier, S. L. Gonias, and W. M. Campana (2008)
J. Neurosci. 28, 11571-11582
   Abstract »    Full Text »    PDF »
Integrin-mediated Protein Kinase A Activation at the Leading Edge of Migrating Cells.
C. J. Lim, K. H. Kain, E. Tkachenko, L. E. Goldfinger, E. Gutierrez, M. D. Allen, A. Groisman, J. Zhang, and M. H. Ginsberg (2008)
Mol. Biol. Cell 19, 4930-4941
   Abstract »    Full Text »    PDF »
p75 neurotrophin receptor regulates agonist-induced pulmonary vasoconstriction.
M. Xu, C. V. Remillard, B. D. Sachs, A. Makino, O. Platoshyn, W. Yao, W. H. Dillmann, K. Akassoglou, and J. X.-J. Yuan (2008)
Am J Physiol Heart Circ Physiol 295, H1529-H1538
   Abstract »    Full Text »    PDF »
Tyrosine 302 in RACK1 Is Essential for Insulin-like Growth Factor-I-mediated Competitive Binding of PP2A and {beta}1 Integrin and for Tumor Cell Proliferation and Migration.
P. A. Kiely, G. S. Baillie, M. J. Lynch, M. D. Houslay, and R. O'Connor (2008)
J. Biol. Chem. 283, 22952-22961
   Abstract »    Full Text »    PDF »
Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury.
Y. P. de Visser, F. J. Walther, E. H. Laghmani, S. van Wijngaarden, K. Nieuwland, and G. T. M. Wagenaar (2008)
Eur. Respir. J. 31, 633-644
   Abstract »    Full Text »    PDF »
Mechanisms of Fibrogenesis.
T. Kisseleva and D. A. Brenner (2008)
Experimental Biology and Medicine 233, 109-122
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882